Inve US ▾
MMMMS

Maximus (MMS) Q3 FY26 earnings call: guidance and Q&A

Earnings call· Jun 2026 (Q3 FY26)· Industrials· Aug 6, 2026

Source: earnings call transcript

Executive summary

Maximus Q3 FY26 — Strong Execution Amidst VA MDE Incentive Pause

Maximus delivered strong Q3 FY26 results, marked by margin improvement and increased adjusted EPS, despite a customer-directed pause in performance incentives for the VA MDE program impacting the near-term outlook. The company is navigating procurement delays in the federal civilian market while seeing momentum in AI-enabled solutions, SNAP, and defense, and remains focused on strategic capital deployment and long-term growth.

Highlights

5
  • Adjusted EBITDA margin improved to 15.0% in Q3 FY26 from 14.7% in the prior year period.

  • Adjusted EPS increased to $2.22 in Q3 FY26 from $2.16 in the prior year period.

  • Collections from a major federal customer accelerated, with approximately $245 million received since June 30.

  • Repurchased approximately 0.75 million shares totaling $50 million in Q3 FY26.

  • Balance of awarded but not yet signed contracts stepped up to $1.35 billion, driven primarily by successful longer-term recompete activity.

Concerns

4
  • Customer-directed pause in performance incentives on the VA MDE program is expected to reduce Q4 FY26 diluted EPS guidance by approximately $0.35.

  • DSO remained elevated at 98 days in Q3 FY26 due to administrative delays at a major federal customer.

  • Full-year FY26 revenue guidance was reiterated with a bias towards the lower end of the $5.2 billion to $5.35 billion range.

  • Procurement delays, scope revisions, or cancellations in the federal civilian market are causing opportunities to mature more slowly.

Guidance & targets

CategoryTargetConfidence
Full-year FY26 Revenue
$5.2 billion to $5.35 billion
high materiality
Medium
Full-year FY26 Adjusted Diluted EPS
$7.90 and $8.20 per share
high materiality
Medium
Full-year FY26 Adjusted EBITDA Margin
approximately 13.7%
high materiality
Medium
Full-year FY26 Free Cash Flow
$425 million and $475 million
high materiality
Medium
Full-year FY26 U.S. Federal Services Segment Operating Margin
16.5% and 17.0%
medium materiality
Medium
Q4 FY26 U.S. Federal Services Operating Margin
14.5% and 15.0%
medium materiality
Medium
Full-year FY26 U.S. Services Segment Operating Margin
9.5% to 10.0%
medium materiality
Medium
Full-year FY26 Outside the U.S. Segment Operating Profit
breakeven
medium materiality
Medium
Full-year FY26 Interest Expense
roughly $88 million
low materiality
Medium
Full-year FY26 Tax Rate
24% and 24.5%
low materiality
Medium
DSO (Days Sales Outstanding)
below 70 days
medium materiality
High
VA MDE Incentive Pause Duration
continues through December 31, 2026
high materiality
Medium
U.S. Services Segment Organic Revenue Growth
positive mid-single-digit organic growth
medium materiality
High
Q4 FY26 Adjusted Diluted EPS
$1.91
high materiality
Medium
Q4 FY26 Adjusted EBITDA Margin
approximately 13.7%
high materiality
Medium

Segment performance

SegmentRevenueYoYQoQMargin
U.S. Federal Services
Revenue was in line with expectations. The prior year period benefited from elevated natural disaster support and temporary clinical volume surges. Operating income margin improved to 18.6% from 18.1% in the prior year, driven by efficiencies amidst solid volumes. The VA MDE incentive pause is expected to impact profitability starting Q4.
$721 million——18.6%
U.S. Services
Revenue was consistent with expectations to close the gap to prior year revenues. Operating income margin reflects solid upward progression. Positive mid-single-digit organic growth is anticipated in Q4 FY26 and into FY27, driven by Medicaid population activities.
$418 million——10.8%
Outside the U.S.
Revenue delta versus prior year was due to variances in volumes across several programs, including clinical and employment services. The segment recognized an operating profit of $1.2 million. The goal remains to drive growth and further margin improvement through successful conversion of the sales pipeline.
$140 million——$1.2 million

Orderbook & backlog

Total Pipeline Sales Opportunities $50.4 billion June 30
Proposals Pending $2.9 billion June 30
Proposals in Preparation $2.4 billion June 30
Opportunities Tracking $45.1 billion June 30
Share of New Work in Total Pipeline 57% June 30
U.S. Federal Services Segment's Share of Total Pipeline 55% June 30
Signed Contract Awards Year-to-Date $1.25 billion end of Q3 FY26

Total contract value.

Book-to-Bill Ratio approximately 0.5x trailing 12-month period

Using standard reporting.

Awarded but Not Yet Signed Contracts $1.35 billion June 30

significant step-up from last quarter

Driven primarily by successful longer-term recompete activity; includes deals that have been through the protest process and successfully resolved.

Product announcements

ProductTypeDetails
Spectro Cloudexpansion
Hackathon platformmilestone

Deals & partnerships

Spectro Cloud Strategic investment in an AI infrastructure management software provider.

Maximus Ventures made a direct investment in Spectro Cloud. This partnership aims to bring differentiated capabilities to customers, including preferred access and co-development arrangements, to accelerate deployment, strengthen competitive position, support revenue growth, and increase customer value.

Risks & headwinds

Temporary pause of performance incentives on VA MDE program Effective July 1, 2026, assumed to continue through December 31, 2026 (Q1 FY27).

Reduces Q4 FY26 diluted EPS guidance by approximately $0.35.

Mitigation:Maximus continues to deliver high-quality work and maintains a strong relationship with the VA; views it as an administrative action by the customer to improve their review process.

Elevated Days Sales Outstanding (DSO) Q3 FY26.

98 days in Q3 FY26.

Mitigation:Collections from a major federal customer have accelerated in July, with $245 million received since June 30; expects DSO to be below 70 days by fiscal year-end.

Procurement delays, scope revisions, or cancellations in the federal civilian market Current.

Opportunities maturing more slowly, leading to more bridge contracts and short-term extensions.

Mitigation:Maintaining a disciplined, target-rich pipeline; underlying demand environment remains constructive.

Complexity of CMS interim final rule for Medicaid work requirements Less than 6 months until go-live date (January 1, 2027).

Created additional uncertainty for states, slowing operationalization of compliance requirements.

Mitigation:Underlying need for administrative support, beneficiary engagement, compliance monitoring, and technology enablement remains intact; Maximus is engaged with states and a recent court ruling affirmed implementation.

What to watch in Q4 FY26

VA MDE incentive mechanism

Q1 FY27 (after December 31, 2026)
Current Paused, reducing Q4 FY26 EPS by $0.35.
Target Reinstatement of incentives or clarity on successor contract structure.

Why it matters

Directly impacts the profitability of the U.S. Federal Services segment and overall earnings power.

Our assumption based on customer guidance is the temporary pause continues through December 31, 2026. Therefore, we presume that in the first quarter of fiscal year 2027, we will not be eligible to earn incentives.

Find out whether MMS delivers this. Inve re-checks your case every morning.

Q&A highlights

Can you provide more color on the VA's decision to pause incentives and if this is an uncommon occurrence?

Bruce Caswell explained that the VA's decision is a temporary pause to improve their internal review and validation process, not a reflection of Maximus's performance. He noted that while a significant contractual term suspension is not common, it's also not unprecedented for government contracts, and Maximus's model is to support customers through such changes.

“it's not uncommon for our customers to need to respond over the life of the contract... So while it's not common for a significant contractual term like this to be suspended, it's also not unprecedented.”

asked by Will Gildea · answered by Bruce L. Caswell

3 min read 6 chapters

Detailed narrative

VA MDE Contract Modification and Outlook

The Department of Veterans Affairs (VA) implemented a temporary pause in performance incentives for the Medical Disability Exam (MDE) program, effective July 1, 2026. This action is expected to reduce Q4 FY26 diluted EPS by approximately $0.35 and is assumed to continue through December 31, 2026 (Q1 FY27).

Management views this as an administrative measure by the customer to improve their review process, not a reflection of Maximus's performance, and maintains a strong relationship with the VA. A Draft Performance Work Statement (PWS) for the next contract has been released, indicating consistent scope and inclusion of all six regions, bolstering optimism for Maximus's position.

Federal Civilian Market Dynamics and Pipeline

The federal civilian market is experiencing procurement delays, scope revisions, and occasional cancellations due to evolving priorities and budget considerations. This environment has led to an increase in bridge contracts and short-term extensions, causing opportunities to mature more slowly. Despite these challenges, the underlying demand environment remains constructive, with a total pipeline of $50.4 billion as of June 30, including $2.9 billion in proposals pending and $1.35 billion in awarded but unsigned contracts, which are expected to convert to signed contracts in subsequent quarters.

H.R. 1 Opportunities: Medicaid and SNAP

Organic growth in the U.S. Services segment is expected to return in Q4 FY26, driven by increased beneficiary outreach for Medicaid. The complexity of the CMS interim final rule for Medicaid work requirements has slowed states' operationalization efforts, but a recent Federal District Court ruling affirmed the implementation of these requirements by January 1, 2027.

SNAP opportunities are advancing more quickly, with significant customer interest in Maximus's Accuracy Assistant tool, driven by persistently high national payment error rates (10.6% in FY25) and upcoming administrative cost share increases for states.

Accelerated AI Adoption and Strategic Investments

Maximus is actively integrating AI into its solutions and internal operations, with 75% to 80% of new bids and rebids in its pipeline containing explicit AI requirements. Internal AI-based improvements, such as IVR and chatbot optimization, have yielded a 3.5% operating margin improvement in five contracts.

Through Maximus Ventures, the company made a direct investment in Spectro Cloud, an AI infrastructure management software provider, aiming to accelerate secure AI deployment for government customers, particularly in highly regulated defense areas.

Defense and National Security Market Expansion

The defense and national security market is a priority for long-term growth, characterized by strong demand signals and an addressable market of nearly $47 billion. Maximus is expanding its capabilities and market presence, demonstrating success with key wins at the Air Force and Transportation Security Administration.

The company believes that large government customers are increasingly willing to consider capable alternatives outside the traditional provider ecosystem, creating opportunities for differentiated companies with proven execution.

Capital Allocation and Shareholder Returns

Maximus's capital allocation priorities include organic investments, a growing dividend, M&A opportunities, and opportunistic share repurchases. The company repurchased 0.75 million shares totaling $50 million in Q3 FY26, with $400 million remaining under authorization. Since FY25, Maximus has repurchased 8.3 million shares, representing about 14% of beginning outstanding shares.

M&A efforts are focused on expanding capabilities, customer access, and driving long-term organic growth, while maintaining discipline on valuation and leverage targets (2x to 3x net debt ratio).

Summary of the company's earnings call; see how call summaries are prepared. Not investment advice.